Novo Nordisk Wegovy Reduces Liver Fat In Obesity Without Diabetes
A post hoc analysis of data from Novo Nordisk's STEP UP trial shows that its obesity drug Wegovy reduced liver fat in adults who are obese but do not have diabetes.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.